At the media briefing for the 2026 Brain-Computer Interface Conference at the Pujiang Innovation Forum, Hong Bo, chief scientist of the Lingang Laboratory, revealed that approximately 120 patients in China have retained brain-computer interface implants for more than one month without removal, and that this year marks the inaugural year for clinical application of brain-computer interfaces in China. The conference will be held in Shanghai from December 3 to 6 under the theme "Brain Connects the World · Wisdom Gathers in Shanghai," and will feature a main forum, six major industry tracks, and multiple special events. Currently, multiple domestic brain-computer interface technology pathways have made progress, with product development and clinical advancement proceeding smoothly. Shanghai is home to more than 120 brain-computer interface enterprises—about one-third of the national total—with cumulative financing exceeding 4 billion yuan this year, and three enterprises are preparing for IPOs. More than 20 hospitals nationwide have opened brain-computer interface-related outpatient clinics or wards, and Shanghai's "Huhuibao" supplementary insurance program has included related products in its coverage, with reimbursement of up to 30%. The industry faces bottlenecks such as data silos. During the conference, the establishment of a "National EEG Data Center" will be officially launched, structured under the framework of "one center + two core nodes in Shanghai and Beijing + a nationwide network," linking hospitals in the Yangtze River Delta and other regions to promote industry development.